ROHTO PHARMACEUTICAL CO.,LTD. (4527)
Market cap
¥565.1B
P/E ratio
16.4x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
| Period End | FCF margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 9 | -6.99% |
| Mar 31, 2024 | 9.7 | +3.09% |
| Mar 31, 2023 | 9.4 | +10.58% |
| Mar 31, 2022 | 8.5 | +36.63% |
| Mar 31, 2021 | 6.2 | -12.85% |
| Mar 31, 2020 | 7.1 | -14.44% |
| Mar 31, 2019 | 8.3 | +1.32% |
| Mar 31, 2018 | 8.2 | +32.02% |
| Mar 31, 2017 | 6.2 | +54.21% |
| Mar 31, 2016 | 4 | -16.16% |
| Mar 31, 2015 | 4.8 |